Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - Two sides of a coin

Journal of Cell Science

Volumn 122, Issue 11, 2009, Pages 1723-1736

  Capparuccia, Lorena ^a   Tamagnone, Luca ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Plexins; Semaphorins; Tumor; Tumor microenvironment

Indexed keywords

NEUROPILIN; NEUROPILIN 1; NEUROPILIN 2; PLEXIN; PLEXIN A; PLEXIN B1; PLEXIN C1; PLEXIN D1; SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 3B; SEMAPHORIN 3C; SEMAPHORIN 3D; SEMAPHORIN 3F; SEMAPHORIN 4A; SEMAPHORIN 6A; SEMAPHORIN 7A; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE RELEASE; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION PROFILING; HUMAN; LEUKOCYTE; MOLECULAR INTERACTION; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; PERICYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STROMA CELL; THROMBOCYTE AGGREGATION INHIBITION; TUMOR CELL; TUMOR VASCULARIZATION;

HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; SEMAPHORINS; SIGNAL TRANSDUCTION;

EID: 69449097679     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.030197     Document Type: Article

References (176)

1. Acevedo, L. M., Barillas, S., Weis, S. M., Gothert, J. R. and Cheresh, D. A. (2008). Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 111, 2674-2680.
2. Allavena, P., Garlanda, C., Borrello, M. G., Sica, A. and Mantovani, A. (2008). Pathways connecting inflammation and cancer. Curr. Opin. Genet. Dev. 18, 3-10.
3. Appleton, B. A., Wu, P., Maloney, J., Yin, J., Liang, W. C., Stawicki, S., Mortara, K., Bowman, K. K., Elliott, J. M., Desmarais, W. et al. (2007). Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J. 26, 4902-4912.
4. Artigiani, S., Barberis, D., Fazzari, P., Longati, P., Angelini, P., van de Loo, J. W., Comoglio, P. M. and Tamagnone, L. (2003). Functional regulation of semaphorin receptors by proprotein convertases. J. Biol. Chem. 278, 10094-10101.
5. Avraamides, C. J., Garmy-Susini, B. and Varner, J. A. (2008). Integrins in angiogenesis and lymphangiogenesis. Nat. Rev. Cancer 8, 604-617.
6. Ayala, G. E., Dai, H., Powell, M., Li, R., Ding, Y., Wheeler, T. M., Shine, D., Kadmon, D., Thompson, T., Miles, B. J. et al. (2008). Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin. Cancer Res. 14, 7593-7603.
7. Bachelder, R. E., Lipscomb, E. A., Lin, X., Wendt, M. A., Chadborn, N. H., Eickholt, B. J. and Mercurio, A. M. (2003). Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res. 63, 5230-5233.
8. Banu, N., Teichman, J., Dunlap-Brown, M., Villegas, G. and Tufro, A. (2006). Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J. 20, 2150-2152.
9. Barberis, D., Artigiani, S., Casazza, A., Corso, S., Giordano, S., Love, C. A., Jones, E. Y., Comoglio, P. M. and Tamagnone, L. (2004). Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J. 18, 592-594.
10. Barr, M. P., Byrne, A. M., Duffy, A. M., Condron, C. M., Devocelle, M., Harriott, P., Bouchier-Hayes, D. J. and Harmey, J. H. (2005). A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells. Br. J. Cancer 92, 328-333.
11. Basile, J. R., Barac, A., Zhu, T., Guan, K. L. and Gutkind, J. S. (2004). Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res. 64, 5212-5224.
12. Basile, J. R., Afkhami, T. and Gutkind, J. S. (2005). Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol. Cell. Biol. 25, 6889-6898.
13. Basile, J. R., Gavard, J. and Gutkind, J. S. (2007a). Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J. Biol. Chem. 282, 34888-34895.
14. Basile, J. R., Holmbeck, K., Bugge, T. H. and Gutkind, J. S. (2007b). MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J. Biol. Chem. 282, 6899-6905.
15. Ben-Zvi, A., Manor, O., Schachner, M., Yaron, A., Tessier-Lavigne, M. and Behar, O. (2008). The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal root ganglia development. J. Neurosci. 28, 12427-12432.
16. Bielenberg, D. R., Hida, Y., Shimizu, A., Kaipainen, A., Kreuter, M., Kim, C. C. and Klagsbrun, M. (2004). Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J. Clin. Invest. 114, 1260-1271.
17. Bielenberg, D. R., Pettaway, C. A., Takashima, S. and Klagsbrun, M. (2006). Neuropilins in neoplasms: expression, regulation, and function. Exp. Cell Res. 312, 584-593.
18. Bielenberg, D. R., Shimizu, A. and Klagsbrun, M. (2008). Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells. Methods Enzymol. 443, 299-314.
19. Biswas, S. K., Sica, A. and Lewis, C. E. (2008). Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180, 2011-2017.
20. Boccaccio, C. and Comoglio, P. M. (2005). A functional role for hemostasis in early cancer development. Cancer Res. 65, 8579-8582.
21. Bork, P., Doerks, T., Springer, T. A. and Snel, B. (1999). Domains in plexins: links to integrins and transcription factors. Trends Biochem. Sci. 24, 261-263.
22. Borsig, L. (2008). The role of platelet activation in tumor metastasis. Expert Rev. Anticancer. Ther. 8, 1247-1255.
23. Brambilla, E., Constantin, B., Drabkin, H. and Roche, J. (2000). Semaphorin SEMA3F localization in malignant human lung and cell lines: a suggested role in cell adhesion and cell migration. Am. J. Pathol. 156, 939-950.
24. Casazza, A., Fazzari, P. and Tamagnone, L. (2007). Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms. Adv. Exp. Med. Biol. 600, 90-108.
25. Castellani, V. and Rougon, G. (2002). Control of semaphorin signaling. Curr. Opin. Neurobiol. 12, 532.
26. Castro-Rivera, E., Ran, S., Thorpe, P. and Minna, J. D. (2004). Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc. Natl. Acad. Sci. USA 101, 11432-11437.
27. Castro-Rivera, E., Ran, S., Brekken, R. A. and Minna, J. D. (2008). Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res. 68, 8295-8303.
28. Catalano, A., Caprari, P., Rodilossi, S., Betta, P., Castellucci, M., Casazza, A., Tamagnone, L. and Procopio, A. (2004). Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J. 18, 358-360.
29. Catalano, A., Caprari, P., Moretti, S., Faronato, M., Tamagnone, L. and Procopio, A. (2006). Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107, 3321-3329.
30. Caunt, M., Mak, J., Liang, W. C., Stawicki, S., Pan, Q., Tong, R. K., Kowalski, J., Ho, C., Reslan, H. B., Ross, J. et al. (2008). Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13, 331-342.
31. Chabbert-de Ponnat, I., Buffard, V., Leroy, K., Bagot, M., Bensussan, A., Wolkenstein, P. and Marie-Cardine, A. (2006). Antiproliferative effect of semaphorin 3F on human melanoma cell lines. J. Invest. Dermatol. 126, 2343-2345.
32. Chaput, N., Conforti, R., Viaud, S., Spatz, A. and Zitvogel, L. (2008). The Janus face of dendritic cells in cancer. Oncogene 27, 5920-5931.
33. Chauvet, S., Cohen, S., Yoshida, Y., Fekrane, L., Livet, J., Gayet, O., Segu, L., Buhot, M. C., Jessell, T. M., Henderson, C. E. et al. (2007). Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron 56, 807-822.
34. Christensen, C. R., Klingelhofer, J., Tarabykina, S., Hulgaard, E. F., Kramerov, D. and Lukanidin, E. (1998). Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res. 58, 1238-1244.
35. Christensen, C., Ambartsumian, N., Gilestro, G., Thomsen, B., Comoglio, P., Tamagnone, L., Guldberg, P. and Lukanidin, E. (2005). Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res. 65, 6167-6177.
36. Conrotto, P., Corso, S., Gamberini, S., Comoglio, P. M. and Giordano, S. (2004). Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 23, 5131-5137.
37. Conrotto, P., Valdembri, D., Corso, S., Serini, G., Tamagnone, L., Comoglio, P. M., Bussolino, F. and Giordano, S. (2005). Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105, 4321-4329.
38. Czopik, A. K., Bynoe, M. S., Palm, N., Raine, C. S. and Medzhitov, R. (2006). Semaphorin 7A is a negative regulator of T cell responses. Immunity 24, 591-600.
39. Deaglio, S., Vaisitti, T., Bergui, L., Bonello, L., Horenstein, A. L., Tamagnone, L., Boumsell, L. and Malavasi, F. (2005). CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 105, 3042-3050.
40. Delaire, S., Billard, C., Tordjman, R., Chedotal, A., Elhabazi, A., Bensussan, A. and Boumsell, L. (2001). Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J. Immunol. 166, 4348-4354.
41. Dhanabal, M., Wu, F., Alvarez, E., McQueeney, K. D., Jeffers, M., Macdougall, J., Boldog, F. L., Hackett, C., Shenoy, S., Khramtsov, N. et al. (2005). Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis. Cancer Biol. Ther. 4, 659-668.
42. Dolcetti, L., Marigo, I., Mantelli, B., Peranzoni, E., Zanovello, P. and Bronte, V. (2008). Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Lett. 267, 216-225.
43. Elhabazi, A., Delaire, S., Bensussan, A., Boumsell, L. and Bismuth, G. (2001). Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J. Immunol. 166, 4341-4347.
44. Ellis, L. M. (2006). The role of neuropilins in cancer. Mol. Cancer Ther. 5, 1099-1107.
45. Entschladen, F., Palm, D., Lang, K., Drell, T. L. and Zaenker, K. S. (2006). Neoneurogenesis: tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med. Hypotheses 67, 33-35.
46. Entschladen, F., Palm, D., Drell, T. L., Lang, K. and Zaenker, K. S. (2007). Connecting a tumor to the environment. Curr. Pharm. Des. 13, 3440-3444.
47. Fazzari, P., Penachioni, J., Gianola, S., Rossi, F., Eickholt, B. J., Maina, F., Alexopoulou, L., Sottile, A., Comoglio, P. M., Flavell, R. A. et al. (2007). Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Dev. Biol. 7, 55.
48. Franco, M. and Tamagnone, L. (2008). Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive. EMBO Rep. 9, 865-871.
49. Fujii, T., Nakao, F., Shibata, Y., Shioi, G., Kodama, E., Fujisawa, H. and Takagi, S. (2002). Caenorhabditis elegans PlexinA, PLX-1, interacts with transmembrane semaphorins and regulates epidermal morphogenesis. Development 129, 2053-2063.
50. Fukasawa, M., Matsushita, A. and Korc, M. (2007). Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol. Ther. 6, 1173-1180.
51. Futamura, M., Kamino, H., Miyamoto, Y., Kitamura, N., Nakamura, Y., Ohnishi, S., Masuda, Y. and Arakawa, H. (2007). Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res. 67, 1451-1460.
52. Galani, E., Sgouros, J., Petropoulou, C., Janinis, J., Aravantinos, G., Dionysiou-Asteriou, D., Skarlos, D. and Gonos, E. (2002). Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients. Anticancer Res. 22, 2275-2280.
53. Geretti, E., Shimizu, A. and Klagsbrun, M. (2008). Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39.
54. Gherardi, E., Love, C. A., Esnouf, R. M. and Jones, E. Y. (2004). The sema domain. Curr. Opin. Struct. Biol. 14, 669-678.
55. Ghosh, S., Sullivan, C. A., Zerkowski, M. P., Molinaro, A. M., Rimm, D. L., Camp, R. L. and Chung, G. G. (2008). High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer. Hum. Pathol. 39, 1835-1843.
56. Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L. and Comoglio, P. M. (2002). The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat. Cell Biol. 4, 720-724.
57. Glinka, Y. and Prud'homme, G. J. (2008). Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J. Leukoc. Biol. 84, 302-310.
58. Gomez Roman, J. J., Garay, G. O., Saenz, P., Escuredo, K., Sanz, I. C., Gutkind, S., Junquera, C., Simon, L., Martinez, A., Fernandez Luna, J. L. et al. (2008). Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth. Transl. Res. 151, 134-140.
59. Goodman, C. S., Kolodkin, A. L., Luo, Y., Pueschel, A. W. and Raper, J. A. (1999). Unified nomenclature for the semaphorins collapsins. Cell 97, 551-552.
60. Granziero, L., Circosta, P., Scielzo, C., Frisaldi, E., Stella, S., Geuna, M., Giordano, S., Ghia, P. and Caligaris-Cappio, F. (2003). CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. Blood 101, 1962-1969.
61. Gray, M. J., Wey, J. S., Belcheva, A., McCarty, M. F., Trevino, J. G., Evans, D. B., Ellis, L. M. and Gallick, G. E. (2005). Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res. 65, 3664-3670.
62. Gray, M. J., Van Buren, G., Dallas, N. A., Xia, L., Wang, X., Yang, A. D., Somcio, R. J., Lin, Y. G., Lim, S., Fan, F. et al. (2008). Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J. Natl. Cancer Inst. 100, 109-120.
63. Gu, C., Limberg, B. J., Whitaker, G. B., Perman, B., Leahy, D. J., Rosenbaum, J. S., Ginty, D. D. and Kolodkin, A. L. (2002). Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J. Biol. Chem. 277, 18069-18076.
64. Gu, C., Yoshida, Y., Livet, J., Reimert, D. V., Mann, F., Merte, J., Henderson, C. E., Jessell, T. M., Kolodkin, A. L. and Ginty, D. D. (2005). Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307, 265-268.
65. Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G. and Giancotti, F. G. (2006). Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126, 489-502.
66. Gupta, G. P. and Massague, J. (2004). Platelets and metastasis revisited: a novel fatty link. J. Clin. Invest. 114, 1691-1693.
67. Guttmann-Raviv, N., Kessler, O., Shraga-Heled, N., Lange, T., Herzog, Y. and Neufeld, G. (2006). The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett. 231, 1-11.
68. Guttmann-Raviv, N., Shraga-Heled, N., Varshavsky, A., Guimaraes-Sternberg, C., Kessler, O. and Neufeld, G. (2007). Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem. 282, 26294-26305.
69. Hall, K. T., Boumsell, L., Schultze, J. L., Boussiotis, V. A., Dorfman, D. M., Cardoso, A. A., Bensussan, A., Nadler, L. M. and Freeman, G. J. (1996). Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc. Natl. Acad. Sci. USA 93, 11780-11785.
70. Halloran, M. C. and Wolman, M. A. (2006). Repulsion or adhesion: receptors make the call. Curr. Opin. Cell Biol. 18, 533-540.
71. Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
72. Handa, A., Tokunaga, T., Tsuchida, T., Lee, Y. H., Kijima, H., Yamazaki, H., Ueyama, Y., Fukuda, H. and Nakamura, M. (2000). Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int. J. Oncol. 17, 291-295.
73. Hansel, D. E., Wilentz, R. E., Yeo, C. J., Schulick, R. D., Montgomery, E. and Maitra, A. (2004). Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am. J. Surg. Pathol. 28, 347-356.
74. He, Z. and Tessier-Lavigne, M. (1997). Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90, 739-751.
75. He, Z., Wang, K. C., Koprivica, V., Ming, G. and Song, H. J. (2002). Knowing how to navigate: mechanisms of semaphorin signaling in the nervous system. Sci. STKE 2002, RE1.
76. Herman, J. G. and Meadows, G. G. (2007). Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. Int. J. Oncol. 30, 1231-1238.
77. Holmes, S., Downs, A. M., Fosberry, A., Hayes, P. D., Michalovich, D., Murdoch, P., Moores, K., Fox, J., Deen, K., Pettman, G. et al. (2002). Sema7A is a potent monocyte stimulator. Scand. J. Immunol. 56, 270-275.
78. Hsieh, S. H., Ying, N. W., Wu, M. H., Chiang, W. F., Hsu, C. L., Wong, T. Y., Jin, Y. T., Hong, T. M. and Chen, Y. L. (2008). Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27, 3746-3753.
79. Ito, Y., Oinuma, I., Katoh, H., Kaibuchi, K. and Negishi, M. (2006). Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse. EMBO Rep. 7, 704-709.
80. Kamiya, T., Kawakami, T., Abe, Y., Nishi, M., Onoda, N., Miyazaki, N., Oida, Y., Yamazaki, H., Ueyama, Y. and Nakamura, M. (2006). The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer. Oncol. Rep. 15, 369-373.
81. Kashiwagi, H., Shiraga, M., Kato, H., Kamae, T., Yamamoto, N., Tadokoro, S., Kurata, Y., Tomiyama, Y. and Kanakura, Y. (2005). Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A. Blood 106, 913-921.
82. Kessler, O., Shraga-Heled, N., Lange, T., Gutmann-Raviv, N., Sabo, E., Baruch, L., Machluf, M. and Neufeld, G. (2004). Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res. 64, 1008-1015.
83. Kigel, B., Varshavsky, A., Kessler, O. and Neufeld, G. (2008). Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PloS ONE 3, e3287.
84. Kikutani, H. and Kumanogoh, A. (2003). Semaphorins in interactions between T cells and antigen-presenting cells. Nat. Rev. Immunol. 3, 159-167.
85. Kolodkin, A. L. and Ginty, D. D. (1997). Steering clear of semaphorins: neuropilins sound the retreat. Neuron 19, 1159-1162.
86. Kolodkin, A. L., Matthes, D. J. and Goodman, C. S. (1993). The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75, 1389-1399.
87. Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y. T., Giger, R. J. and Ginty, D. D. (1997). Neuropilin is a semaphorin III receptor. Cell 90, 753-762.
88. Koppel, A. M., Feiner, L., Kobayashi, H. and Raper, J. A. (1997). A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members. Neuron 19, 531-537.
89. Kumanogoh, A., Watanabe, C., Lee, I., Wang, X., Shi, W., Araki, H., Hirata, H., Iwahori, K., Uchida, J., Yasui, T. et al. (2000). Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13, 621-631.
90. Kumanogoh, A., Marukawa, S., Suzuki, K., Takegahara, N., Watanabe, C., Ch'ng, E., Ishida, I., Fujimura, H., Sakoda, S., Yoshida, K. et al. (2002). Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419, 629-633.
91. Kumanogoh, A., Shikina, T., Suzuki, K., Uematsu, S., Yukawa, K., Kashiwamura, S., Tsutsui, H., Yamamoto, M., Takamatsu, H., Ko-Mitamura, E. P. et al. (2005). Nonredundant roles of Sema4A in the immune system: defective T cell priming and Th1/Th2 regulation in Sema4A-deficient mice. Immunity 22, 305-316.
92. Kuroki, T., Trapasso, F., Yendamuri, S., Matsuyama, A., Alder, H., Williams, N. N., Kaiser, L. R. and Croce, C. M. (2003). Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res. 63, 3352-3353.
93. Kusy, S., Nasarre, P., Chan, D., Potiron, V., Meyronet, D., Gemmill, R. M., Constantin, B., Drabkin, H. A. and Roche, J. (2005). Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia 7, 457-465.
94. Lantuejoul, S., Constantin, B., Drabkin, H., Brambilla, C., Roche, J. and Brambilla, E. (2003). Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J. Pathol. 200, 336-347.
95. Latil, A., Bieche, I., Pesche, S., Valeri, A., Fournier, G., Cussenot, O. and Lidereau, R. (2000). VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int. J. Cancer 89, 167-171.
96. Le Bitoux, M. A. and Stamenkovic, I. (2008). Tumor-host interactions: the role of inflammation. Histochem. Cell Biol. 130, 1079-1090.
97. Leffers, N., Gooden, M. J., de Jong, R. A., Hoogeboom, B. N., Ten Hoor, K. A., Hollema, H., Boezen, H. M., van der Zee, A. G., Daemen, T. and Nijman, H. W. (2008). Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol. Immunother. 58, 449-459.
98. Lepelletier, Y., Moura, I. C., Hadj-Slimane, R., Renand, A., Fiorentino, S., Baude, C., Shirvan, A., Barzilai, A. and Hermine, O. (2006). Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J. Immunol. 36, 1782-1793.
99. Liang, W. C., Dennis, M. S., Stawicki, S., Chanthery, Y., Pan, Q., Chen, Y., Eigenbrot, C., Yin, J., Koch, A. W., Wu, X. et al. (2007). Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J. Mol. Biol. 366, 815-829.
100. Luo, Y., Raible, D. and Raper, J. A. (1993). Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75, 217-227.
101. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
102. Marcus, K., Johnson, M., Adam, R. M., O'Reilly, M. S., Donovan, M., Atala, A., Freeman, M. R. and Soker, S. (2005). Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology 25, 178-187.
103. Martin-Satue, M. and Blanco, J. (1999). Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J. Surg. Oncol. 72, 18-23.
104. Masuda, K., Furuyama, T., Takahara, M., Fujioka, S., Kurinami, H. and Inagaki, S. (2004). Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones. Genes Cells 9, 821-829.
105. Matsushita, A., Gotze, T. and Korc, M. (2007). Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 67, 10309-10316.
106. Miao, H. Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A. and Klagsbrun, M. (1999). Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146, 233-242.
107. Miao, H., Burnett, E., Kinch, M., Simon, E. and Wang, B. (2000). Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat. Cell Biol. 2, 62-69.
108. Moretti, S., Procopio, A., Lazzarini, R., Rippo, M. R., Testa, R., Marra, M., Tamagnone, L. and Catalano, A. (2008). Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts. Blood 111, 2290-2299.
109. Muller, M. W., Giese, N. A., Swiercz, J. M., Ceyhan, G. O., Esposito, I., Hinz, U., Buchler, P., Giese, T., Buchler, M. W., Offermanns, S. et al. (2007). Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int. J. Cancer 121, 2421-2433.
110. Narazaki, M. and Tosato, G. (2006). Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107, 3892-3901.
111. Nasarre, P., Constantin, B., Rouhaud, L., Harnois, T., Raymond, G., Drabkin, H. A., Bourmeyster, N. and Roche, J. (2003). Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia 5, 83-92.
112. Nasarre, P., Kusy, S., Constantin, B., Castellani, V., Drabkin, H. A., Bagnard, D. and Roche, J. (2005). Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia 7, 180-189.
113. Negishi, M., Oinuma, I. and Katoh, H. (2005). R-ras as a key player for signaling pathway of plexins. Mol. Neurobiol. 32, 217-222.
114. Neufeld, G. and Kessler, O. (2008). The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat. Rev. Cancer 8, 632-645.
115. Nguyen, Q. D., Rodrigues, S., Rodrigue, C. M., Rivat, C., Grijelmo, C., Bruyneel, E., Emami, S., Attoub, S. and Gespach, C. (2006). Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A-mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts. Mol. Cancer Ther. 5, 2070-2077.
116. Nishimura, N. and Sasaki, T. (2008). Regulation of epithelial cell adhesion and repulsion: role of endocytic recycling. J. Med. Invest. 55, 9-16.
117. Nonomura, N., Takayama, H., Nishimura, K., Oka, D., Nakai, Y., Shiba, M., Tsujimura, A., Nakayama, M., Aozasa, K. and Okuyama, A. (2007). Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br. J. Cancer 97, 952-956.
118. O'Connor, B. P. and Ting, J. P. (2008). The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function. Immunol. Res. 41, 217-222.
119. Oinuma, I., Ishikawa, Y., Katoh, H. and Negishi, M. (2004). The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305, 862-865.
120. Osada, H., Tokunaga, T., Nishi, M., Hatanaka, H., Abe, Y., Tsugu, A., Kijima, H., Yamazaki, H., Ueyama, Y. and Nakamura, M. (2004). Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res. 24, 547-552.
121. Pan, H., Wanami, L. S., Dissanayake, T. R. and Bachelder, R. E. (2008). Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells. Breast Cancer Res. Treat. doi: 10.1007/s10549-008-0179-y.
122. Pan, Q., Chanthery, Y., Liang, W. C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G. et al. (2007). Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11, 53-67.
123. Pellet-Many, C., Frankel, P., Jia, H. and Zachary, I. (2008). Neuropilins: structure, function and role in disease. Biochem. J. 411, 211-226.
124. Potiron, V. A., Sharma, G., Nasarre, P., Clarhaut, J. A., Augustin, H. G., Gemmill, R. M., Roche, J. and Drabkin, H. A. (2007). Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res. 67, 8708-8715.
125. Potiron, V. A., Roche, J. and Drabkin, H. A. (2009). Semaphorins and their receptors in lung cancer. Cancer Lett. 273, 1-14.
126. Puschel, A. W. (2007). GTPases in semaphorin signaling. Adv. Exp. Med. Biol. 600, 12-23.
127. Rich, J. N., Hans, C., Jones, B., Iversen, E. S., McLendon, R. E., Rasheed, B. K., Dobra, A., Dressman, H. K., Bigner, D. D., Nevins, J. R. et al. (2005). Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 65, 4051-4058.
128. Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., Parsons, J. T. and Horwitz, A. R. (2003). Cell migration: integrating signals from front to back. Science 302, 1704-1709.
129. Rieger, J., Wick, W. and Weller, M. (2003). Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42, 379-389.
130. Roche, J., Boldog, F., Robinson, M., Robinson, L., Varella-Garcia, M., Swanton, M., Waggoner, B., Fishel, R., Franklin, W., Gemmill, R. et al. (1996). Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene 12, 1289-1297.
131. Rody, A., Holtrich, U., Gaetje, R., Gehrmann, M., Engels, K., von Minckwitz, M. G., Loibl, S., Diallo-Danebrock, R., Ruckhaberle, E., Metzler, D. et al. (2007). Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. Clin. Cancer Res. 13, 1115-1122.
132. Rolny, C., Capparuccia, L., Casazza, A., Mazzone, M., Vallario, A., Cignetti, A., Medico, E., Carmeliet, P., Comoglio, P. M. and Tamagnone, L. (2008). The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J. Exp. Med. 205, 1155-1171.
133. Roodink, I., Raats, J., van der Zwaag, B., Verrijp, K., Kusters, B., Van Bokhoven, H., Linkels, M., de Waal, R. M. and Leenders, W. P. (2005). Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy? Cancer Res. 65, 8317-8323.
134. Roodink, I., Kats, G., van Kempen, L., Grunberg, M., Maass, C., Verrijp, K., Raats, J. and Leenders, W. (2008). Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. Am. J. Pathol. 173, 1873-1881.
135. Scott, G. A., McClelland, L. A. and Fricke, A. F. (2008a). Semaphorin 7a promotes spreading and dendricity in human melanocytes through beta1-integrins. J. Invest. Dermatol. 128, 151-161.
136. Scott, G. A., McClelland, L. A., Fricke, A. F. and Fender, A. (2008b). Plexin C1, a receptor for semaphorin 7A, inactivates cofilin and is a potential tumor suppressor for melanoma progression. J. Invest. Dermatol. 129, 954-963.
137. Sekido, Y., Bader, S., Latif, F., Chen, J. Y., Duh, F. M., Wei, M. H., Albanesi, J. P., Lee, C. C., Lerman, M. I. and Minna, J. D. (1996). Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc. Natl. Acad. Sci. USA 93, 4120-4125.
138. Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M. et al. (2003). Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424, 391-397.
139. Serini, G., Napione, L. and Bussolino, F. (2008). Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis. Curr. Opin. Hematol. 15, 235-242.
140. Shi, W., Kumanogoh, A., Watanabe, C., Uchida, J., Wang, X., Yasui, T., Yukawa, K., Ikawa, M., Okabe, M., Parnes, J. R. et al. (2000). The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. Immunity 13, 633-642.
141. Sica, A., Allavena, P. and Mantovani, A. (2008). Cancer related inflammation: the macrophage connection. Cancer Lett. 267, 204-215.
142. Sierko, E. and Wojtukiewicz, M. Z. (2007). Inhibition of platelet function: does it offer a chance of better cancer progression control? Semin. Thromb. Hemost. 33, 712-721.
143. Sierra, J. R., Corso, S., Caione, L., Cepero, V., Conrotto, P., Cignetti, A., Piacibello, W., Kumanogoh, A., Kikutani, H., Comoglio, P. M. et al. (2008). Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J. Exp. Med. 205, 1673-1685.
144. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. and Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell 92, 735-745.
145. Sulpice, E., Plouet, J., Berge, M., Allanic, D., Tobelem, G. and Merkulova-Rainon, T. (2008). Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood 111, 2036-2045.
146. Suzuki, K., Okuno, T., Yamamoto, M., Pasterkamp, R. J., Takegahara, N., Takamatsu, H., Kitao, T., Takagi, J., Rennert, P. D., Kolodkin, A. L. et al. (2007). Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 446, 680-684.
147. Suzuki, K., Kumanogoh, A. and Kikutani, H. (2008). Semaphorins and their receptors in immune cell interactions. Nat. Immunol. 9, 17-23.
148. Swiercz, J. M., Kuner, R. and Offermanns, S. (2004). Plexin-B1/ RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J. Cell Biol. 165, 869-880.
149. Swiercz, J. M., Worzfeld, T. and Offermanns, S. (2008). ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J. Biol. Chem. 283, 1893-1901.
150. Syed, V., Zhang, X., Lau, K. M., Cheng, R., Mukherjee, K. and Ho, S. M. (2005). Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene 24, 8128-8143.
151. Tamagnone, L. and Comoglio, P. M. (2004). To move or not to move? Semaphorin signalling in cell migration. EMBO Rep. 5, 356-361.
152. Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G. I., Song, H., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M. et al. (1999). Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99, 71-80.
153. Taskinen, M., Karjalainen-Lindsberg, M. L. and Leppa, S. (2008). Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood 111, 4664-4667.
154. Thiery, J. P. and Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 7, 131-142.
155. Tomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J.,
156. Toyofuku, T., Zhang, H., Kumanogoh, A., Takegahara, N., Suto, F., Kamei, J., Aoki, K., Yabuki, M., Hori, M., Fujisawa, H. et al. (2004). Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev. 18, 435-447.
157. Toyofuku, T., Yabuki, M., Kamei, J., Kamei, M., Makino, N., Kumanogoh, A. and Hori, M. (2007). Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J. 26, 1373-1384.
158. Tran, T. S., Kolodkin, A. L. and Bharadwaj, R. (2007). Semaphorin regulation of cellular morphology. Annu. Rev. Cell Dev. Biol. 23, 263-292.
159. Trusolino, L., Bertotti, A. and Comoglio, P. M. (2001). A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107, 643-654.
160. Tse, C., Xiang, R. H., Bracht, T. and Naylor, S. L. (2002). Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res. 62, 542-546.
161. Turley, E. A., Veiseh, M., Radisky, D. C. and Bissell, M. J. (2008). Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat. Clin. Pract. Oncol. 5, 280-290.
162. Vacca, A., Scavelli, C., Serini, G., Di, P. G., Cirulli, T., Merchionne, F., Ribatti, D., Bussolino, F., Guidolin, D., Piaggio, G. et al. (2006). Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 108, 1661-1667.
163. Vachkov, I. H., Huang, X., Yamada, Y., Tonchev, A. B., Yamashima, T., Kato, S. and Takakura, N. (2007). Inhibition of axonal outgrowth in the tumor environment: involvement of class 3 semaphorins. Cancer Sci. 98, 1192-1197.
164. Varshavsky, A., Kessler, O., Abramovitch, S., Kigel, B., Zaffryar, S., Akiri, G. and Neufeld, G. (2008). Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases. Cancer Res. 68, 6922-6931.
165. Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., aka-Akita, H. and Nishimura, M. (2003). CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci. 94, 1003-1009.
166. Walzer, T., Galibert, L. and De Smedt, T. (2005). Poxvirus semaphorin A39R inhibits phagocytosis by dendritic cells and neutrophils. Eur. J. Immunol. 35, 391-398.
167. West, D. C., Rees, C. G., Duchesne, L., Patey, S. J., Terry, C. J., Turnbull, J. E., Delehedde, M., Heegaard, C. W., Allain, F., Vanpouille, C. et al. (2005). Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J. Biol. Chem. 280, 13457-13464.
168. Winberg, M. L., Tamagnone, L., Bai, J., Comoglio, P. M., Montell, D. and Goodman, C. S. (2001). The transmembrane protein Off-track associates with Plexins and functions downstream of Semaphorin signaling during axon guidance. Neuron 32, 53-62.
169. Wong, O. G., Nitkunan, T., Oinuma, I., Zhou, C., Blanc, V., Brown, R. S., Bott, S. R., Nariculam, J., Box, G., Munson, P. et al. (2007). Plexin-B1 mutations in prostate cancer. Proc. Natl. Acad. Sci. USA 104, 19040-19045.
170. Xiang, R., Davalos, A. R., Hensel, C. H., Zhou, X. J., Tse, C. and Naylor, S. L. (2002). Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. Cancer Res. 62, 2637-2643.
171. Yamada, T., Endo, R., Gotoh, M. and Hirohashi, S. (1997). Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc. Natl. Acad. Sci. USA 94, 14713-14718.
172. Yamamoto, M., Suzuki, K., Okuno, T., Ogata, T., Takegahara, N., Takamatsu, H., Mizui, M., Taniguchi, M., Chedotal, A., Suto, F. et al. (2008). Plexin-A4 negatively regulates T lymphocyte responses. Int. Immunol. 20, 413-420.
173. Zhao, X. Y., Chen, L., Xu, Q. and Li, Y. H. (2006). Expression of semaphorin 6D in gastric carcinoma and its significance. World J. Gastroenterol. 12, 7388-7390.
174. Zhao, X. Y., Chen, L., Li, Y. H. and Xu, Q. (2007). PlexinA1 expression in gastric carcinoma and its relationship with tumor angiogenesis and proliferation. World J. Gastroenterol. 13, 6558-6561.
175. Zhou, Y., Gunput, R. A. and Pasterkamp, R. J. (2008). Semaphorin signaling: progress made and promises ahead. Trends Biochem. Sci. 33, 161-170.
176. Zhu, L., Bergmeier, W., Wu, J., Jiang, H., Stalker, T. J., Cieslak, M., Fan, R., Boumsell, L., Kumanogoh, A., Kikutani, H. et al. (2007). Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc. Natl. Acad. Sci. USA 104, 1621-1626.